Company Search:
Advanced Search
Sponsored Links
Medite Cancer Diagnostics Inc Company Snapshot
Medite Cancer Diagnostics Inc operates in the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medite Cancer Diagnostics Inc with three other companies in this sector in the United States: Cytori Therapeutics, Inc. (2016 sales of $11.38 million ), Encision Inc. ($9.34 million ), and Cytosorbents Corporation ($9.53 million of which 100% was Medical technology).

Sales Analysis. Medite Cancer Diagnostics Inc reported sales of $9.24 million for the year ending December of 2016. This represents a decrease of 6.6% versus 2015, when the company's sales were $9.89 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medite Cancer Diagnostics Inc
  Stock Performance Chart for Medite Cancer Diagnostics Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/5/2017): .50
(Figures in U.S. Dollars)
1 Week -34.2%   13 Weeks -28.6%  
4 Weeks n/a   52 Weeks 0.0%  
Medite Cancer Diagnostics Inc Key Data:
  Ticker: MDIT Country: United States
  Exchanges: FRA OTC Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2016 Sales 9,238,000
(Year Ending Jan 2017).
Employees: 6
  Currency: U.S. Dollars Market Cap: 14,418,186
  Fiscal Yr Ends: December Shares Outstanding: 28,836,371
  Share Type: Common Closely Held Shares: 18,086,989
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.